Speakers:

– Anand Anandkumar, Co-founder and CEO Bugworks Research Inc (India)

– Kamini Walia, Program Officer, ICMR-AMR Initiative (India)

Moderator: François Franceschi, GARDP

In this webinar, Anand Anandkumar and Kamini Walia will discuss:

– Why is India one of the hotbeds of the AMR problem? Latest statistics of growing drug resistance etc.

– Initiatives of the Indian Government to curb the AMR problem

– Antimicrobial R&D landscape in India – a vibrant ecosystem supporting innovation in AMR diagnosis, prevention and therapeutics

– Fledgling antimicrobial clinical trial networks – could trials out of India play a significant role in gaining global regulatory approvals?

– Changing regulatory environment to enable accelerated approvals for antimicrobial products

The presentation were followed by a Q&A session.